Biosound Esaote demonstrates MyLab30CV with new software

TriMed Staff | | Health Imaging | Diagnostic Imaging
Biosound Esaote showcased new software available for its MyLab30CV high-performance, portable ultrasound system at this week's American College of Cardiology Conference, March 6 - 8, in Orlando, Fla.
   
The 19-pound ultrasound system is capable of meeting all diagnostic requirements in cardiovascular applications, including adult and pediatric scanning in the hospital setting, NICU and outreach programs. Image quality is suitable at the critical care bedside, MPTE in the operating room, stress echo in the office or whole body imaging for the mobile service, said Jim Chapman, director of product marketing.

The newest software available for the system - version 3.0 - enhances the functionality of the system's technology by optimizing digital management and extending the functionality of transducers - phased, linear, curved array and TE. The software is available now.
   
Adding to its line of diagnostic, portable ultrasound systems, Biosound Esaote also unveiled MyLab25. According to the company, the system appeals to vascular laboratories that need portability and high-performance imaging.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup